Literature DB >> 12490388

Expression of a full-length hepatitis C virus cDNA up-regulates the expression of CC chemokines MCP-1 and RANTES.

Hui Meng Soo1, Alfredo Garzino-Demo, Wanjin Hong, Yin Hwee Tan, Yee Joo Tan, Phuay Yee Goh, Seng Gee Lim, Siew Pheng Lim.   

Abstract

We had previously reported the cloning of the complete genome of an isolate of hepatitis C virus (HCV), HCV-S1, of genotype 1b. We have constructed a full-length complementary DNA (cDNA) clone of HCV-S1 using nine overlapping cDNA clones that encompassed its entire genome. HCV core, E1, E2, NS-3, -4B, -5A, and -5B proteins were detected in 293T cells by immunoblot analyses when expression of the full-length HCV-S1 was driven under a CMV promoter. Expression of full-length HCV-S1 led to induction of the CC chemokines RANTES and MCP-1 at both the mRNA and the protein levels in HeLa, Huh7, and HepG2 cells. Reporter gene assays showed that a minimal MCP-1 promoter construct containing 128 nucleotides upstream of its translational start site was sufficient for optimal HCV-mediated activation. HCV induced AP-1 binding activities to this region, as determined from electrophoretic mobility shift assays and supershifts with anti-AP-1 antibodies. Transfection of full-length HCV-S1 up-regulated both AP-1 binding activities as well as c-jun transcripts. A minimal promoter construct containing 181 nucleotides upstream of the RANTES translational start site was sufficient for maximal HCV-mediated induction. Gel mobility shift and supershift assays showed that HCV induced NF-kappaB and other unknown binding activities to the A/B-site within this region. In HeLa cells, HCV core and NS5A could separately augment promoter activities of both MCP-1 and RANTES. In Huh7 cells, only NS5A produced a similar effect, while rather surprisingly, HCV core induced a dramatic reduction in promoter activities of these two genes. This study provides the first direct evidence for the induction of CC chemokines in HCV infection and draws attention to their roles in affecting the progress and outcome of HCV-associated liver diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12490388     DOI: 10.1006/viro.2002.1617

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  22 in total

1.  Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis C.

Authors:  Ying Huang; Jordan J Feld; Ronda K Sapp; Santosh Nanda; Jiing-Huey Lin; Lawrence M Blatt; Michael W Fried; Krishna Murthy; T Jake Liang
Journal:  Gastroenterology       Date:  2006-11-29       Impact factor: 22.682

2.  Distribution and effects of polymorphic RANTES gene alleles in HIV/HCV coinfection -- a prospective cross-sectional study.

Authors:  Golo Ahlenstiel; Agathe Iwan; Jacob Nattermann; Karin Bueren; Jurgen K Rockstroh; Hans H Brackmann; Bernd Kupfer; Olfert Landt; Amnon Peled; Tilman Sauerbruch; Ulrich Spengler; Rainer P Woitas
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

Review 3.  The role of chemokines in acute and chronic hepatitis C infection.

Authors:  Stephen Fahey; Eugene Dempsey; Aideen Long
Journal:  Cell Mol Immunol       Date:  2013-08-19       Impact factor: 11.530

4.  Monocyte chemotactic protein-1 and soluble adhesion molecules as possible prognostic markers of the efficacy of antiviral treatment in chronic hepatitis C.

Authors:  Anatol Panasiuk; Danuta Prokopowicz; Bozena Panasiuk
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

5.  Responses of nontransformed human hepatocytes to conditional expression of full-length hepatitis C virus open reading frame.

Authors:  Weiliang Tang; Catherine A Lázaro; Jean S Campbell; W Tony Parks; Michael G Katze; Nelson Fausto
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

6.  The hepatitis C virus core protein contains a BH3 domain that regulates apoptosis through specific interaction with human Mcl-1.

Authors:  Nur Khairiah Mohd-Ismail; Lin Deng; Sunil Kumar Sukumaran; Victor C Yu; Hak Hotta; Yee-Joo Tan
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

7.  Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro.

Authors:  Karla J Helbig; Andrew Ruszkiewicz; Robert E Lanford; Mark D Berzsenyi; Hugh A Harley; Shaun R McColl; Michael R Beard
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

8.  Sodium tanshinone IIA sulfonate protects mice from ConA-induced hepatitis via inhibiting NF-kappaB and IFN-gamma/STAT1 pathways.

Authors:  Yan Xu; Dechun Feng; Ying Wang; Shuting Lin; Lingyun Xu
Journal:  J Clin Immunol       Date:  2008-05-24       Impact factor: 8.317

9.  Hepatitis C virus non-structural 5A protein can enhance full-length core protein-induced nuclear factor-kappaB activation.

Authors:  Qing-Jiao Liao; Lin-Bai Ye; Khalid Amine Timani; Ying-Long She; Xiao-Jun Yang; Li Ye; Zheng-Hui Wu
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

10.  Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers.

Authors:  Xinxia Peng; Yu Li; Kathie-Anne Walters; Elizabeth R Rosenzweig; Sharon L Lederer; Lauri D Aicher; Sean Proll; Michael G Katze
Journal:  BMC Genomics       Date:  2009-08-11       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.